Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inotiv (NOTV) Gains from Investment Securities (2016 - 2025)

Inotiv (NOTV) has disclosed Gains from Investment Securities for 15 consecutive years, with $271000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Gains from Investment Securities fell 9.06% year-over-year to $271000.0, compared with a TTM value of -$27000.0 through Dec 2024, down 100.75%, and an annual FY2023 reading of $7.1 million, changed N/A over the prior year.
  • Gains from Investment Securities was $271000.0 for Q4 2024 at Inotiv, up from -$1.5 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.3 million in Q4 2022 and bottomed at -$1.5 million in Q3 2024.
  • Average Gains from Investment Securities over 5 years is $284503.9, with a median of $141000.0 recorded in 2020.
  • Peak annual rise in Gains from Investment Securities hit 1291.41% in 2022, while the deepest fall reached 254.86% in 2022.
  • Year by year, Gains from Investment Securities stood at $108000.0 in 2020, then soared by 50.93% to $163000.0 in 2021, then skyrocketed by 1291.41% to $2.3 million in 2022, then crashed by 86.86% to $298000.0 in 2023, then decreased by 9.06% to $271000.0 in 2024.
  • Business Quant data shows Gains from Investment Securities for NOTV at $271000.0 in Q4 2024, -$1.5 million in Q3 2024, and $342000.0 in Q2 2024.